Journal
JOURNAL OF CANCER
Volume 13, Issue 2, Pages 508-516Publisher
IVYSPRING INT PUBL
DOI: 10.7150/jca.65587
Keywords
ETNK2; PTC; Hippo; EMT
Categories
Funding
- Scientific Research Foundation of Wenzhou, Zhejiang Province, China [Y20211121]
Ask authors/readers for more resources
ETNK2 is associated with the occurrence and development of papillary thyroid carcinoma, and may be an oncogene associated with PTC.
Thyroid cancer is a disease with an extremely high incidence rate and is divided into papillary, follicular, medullary, and undifferentiated thyroid cancers. Among them, papillary carcinoma is the most common subtype. We assessed expression of ETNK2 in public databases and found that ETNK2 is upregulated in PTC. Cohort and RNA sequencing data were used to verify this discovery. To further determine the relationship between ETNK2 and papillary thyroid carcinoma, we performed an in vitro experiment. In a PTC cell line, silencing ETNK2 inhibited cell proliferation, weakened cell migration and invasion ability, promoted apoptosis, and blocked the cell cycle. In addition, western blotting suggested that ETNK2 is related to the HIPPO pathway and may activate the EMT pathway through the HIPPO pathway to promote the development of thyroid cancer. These results revealed that ETNK2 is related to the occurrence and development of papillary thyroid carcinoma, suggesting that ETNK2 may be an oncogene associated with PTC.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available